Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionsodium ion transmembrane transporter activity

SLC34A2 SLC8B1

2.52e-0317192GO:0015081
GeneOntologyMolecularFunctionsecondary active transmembrane transporter activity

SLC34A2 SLC8B1

7.36e-0329692GO:0015291
GeneOntologyMolecularFunctionactive monoatomic ion transmembrane transporter activity

SLC34A2 SLC8B1

7.60e-0330192GO:0022853
GeneOntologyMolecularFunctionmetal ion transmembrane transporter activity

SLC34A2 SLC8B1

1.75e-0246592GO:0046873
GeneOntologyMolecularFunctionactive transmembrane transporter activity

SLC34A2 SLC8B1

1.83e-0247792GO:0022804
GeneOntologyCellularComponentbrush border membrane

PLB1 SLC34A2

5.51e-048392GO:0031526
GeneOntologyCellularComponentapical plasma membrane

PLB1 CA12 SLC34A2

9.51e-0448793GO:0016324
GeneOntologyCellularComponentapical part of cell

PLB1 CA12 SLC34A2

1.67e-0359293GO:0045177
GeneOntologyCellularComponentbrush border

PLB1 SLC34A2

1.83e-0315292GO:0005903
GeneOntologyCellularComponentcluster of actin-based cell projections

PLB1 SLC34A2

3.88e-0322392GO:0098862
PathwayREACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES

SLC34A2 SLC8B1

1.19e-0310872M823
PathwayREACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES

SLC34A2 SLC8B1

1.21e-0310972MM15074
PathwayREACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT

SLC34A2 SLC8B1

5.64e-0323872MM15076
PathwayREACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT

SLC34A2 SLC8B1

6.15e-0324972M5988
GeneFamilySolute carriers

SLC34A2 SLC8B1

9.30e-0339572752
CoexpressionAtlasDE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05

UNC50 SLC34A2 GALNT18

1.17e-0424293PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05
ToppCelldroplet-Tongue-TONGUE-1m-Epithelial-suprabasal_differentiating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PLB1 CA12 GALNT18

6.41e-061939349f4fbec91acda4727703e0e359ed780eefb8a22
ToppCell356C-Lymphocytic-NK_cells-NK_cell_C|NK_cells / Donor, Lineage, Cell class and subclass (all cells)

LRIG2 GALNT18

1.87e-0533925ce59ecc7f8432b14dc6cb9af56e1bf080e7d61f
ToppCellfrontal_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Col23a1_Adamts2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

CA12 SLC8B1

7.35e-056592f14b28214f80ed23501ab28ff254c206f70d77b2
ToppCellfrontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_Hsd17b2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

CA12 SLC34A2

1.14e-04819220796e59cdeb398e7772f4356578d74a33405f71
ToppCellfacs-Marrow-T-cells-24m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PLB1 UNC50

1.51e-049392096a207dfd280b23480bc068a15e6947423620c5
ToppCellfacs-Marrow-T-cells-24m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PLB1 UNC50

1.51e-0493926977ae7eccb45fbc48960a0945be9ccc7566ca8b
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Granulocytic-Neutrophil-Neu_c3-CST7|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

PLB1 CA12

4.45e-0416092913e59cecf3b1bdd1ef32b4e320042b9bbdb54bc
ToppCellE16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PLB1 GALNT18

4.56e-041629234b4cd3d2258f88dfbd6d32abd1db87aff8a6b6f
ToppCellE16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PLB1 GALNT18

4.62e-041639256b8668dbf06faa6866ec71f29b92907b73f074d
ToppCell5'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CA12 LRIG2

4.79e-0416692fe006c67a96ffa5a84fba2db96228234668b2a79
ToppCellBasal_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id

GET1 GALNT18

4.79e-041669223c04d1fba0c1733ccd0e4378fae2edde4fd0a7b
ToppCellPND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SLC34A2 GALNT18

5.20e-041739245808cf69122c16b9d2b5ffa06d15392c55954b7
ToppCellPND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SLC34A2 GALNT18

5.20e-04173927fa9dbcb258c3ab974490063951620e2def03db1
ToppCellIPF-Epithelial-Mesothelial|IPF / Disease state, Lineage and Cell class

CA12 GALNT18

5.63e-04180921fa54bf4dba72866b2295639d991af639341bc08
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CA12 GALNT18

5.69e-0418192aa233b652921848af2257cc3687a7a09c3acfb67
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

SLC34A2 GALNT18

5.69e-0418192576da14ab3107f89e1f44a4a439d1bef5bb42370
ToppCellfacs-Lung-18m-Epithelial-airway_epithelial-club_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PLB1 CA12

5.69e-04181924a0f1b121570430afb100c589657d931184e124f
ToppCellfacs-Lung-18m-Epithelial-airway_epithelial-club_cell-club_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PLB1 CA12

5.69e-041819234b49092f71128898af3b311170c4ed8adfefcff
ToppCellfacs-Lung-EPCAM-18m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PLB1 CA12

5.75e-0418292f8eb35eb7f2b8ad47d527ae9ff8a9ddbcd2eedce
ToppCellfacs-Lung-EPCAM-18m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PLB1 CA12

5.75e-04182926685a0abd9c3a79d03b6a578e5d7fa86a9d74117
ToppCellIPF-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class

CA12 GALNT18

5.81e-04183927df20e3172a1220ff427f30181f4f0c3b7fe2d42
ToppCelldroplet-Lung-nan-21m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PLB1 SLC34A2

5.88e-04184927cc3b9bba1f600b40b02fe2456b5d007dbf9fa37
ToppCelldroplet-Lung-nan-21m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PLB1 SLC34A2

5.88e-041849253b71c4ac86dc5e42763b8f64fbc917177531017
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SLC34A2 GALNT18

5.94e-04185924a188e2566a75d1b4f3c879a8c241c277c4b451c
ToppCellCOPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class

CA12 GALNT18

5.94e-041859223579988036fc1925992c31919750f9b3fe9f790
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SLC34A2 GALNT18

5.94e-04185926da9a06e1514d5d5f47359a14637f02539846096
ToppCelldroplet-Fat-Scat-21m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PLB1 SLC34A2

6.00e-0418692de88fafac51049ec1920695844d8ce8057940272
ToppCellE17.5-Epithelial-alveolar_epithelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

PLB1 SLC34A2

6.00e-0418692a7a2ef8392a045a62fa4d0983577711d5d397dc4
ToppCelldroplet-Fat-Scat-21m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PLB1 SLC34A2

6.00e-041869259710cff3f6f7c318ee2524b44c1a909f312c25e
ToppCelldroplet-Fat-Scat-21m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PLB1 SLC34A2

6.00e-04186927ff73ab8fed5da779ee9c7bd2e14a8363edb7509
ToppCelldroplet-Liver-Npc-18m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LRIG2 GALNT18

6.00e-041869275258d88e23112fd1f0f7c71ef0366abb400d33e
ToppCellE17.5-Epithelial|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

PLB1 SLC34A2

6.07e-0418792fdabe716ce67f2eede90548198cbe20bbf693570
ToppCellDiffer-KC|World / shred by cell class for mouse tongue

PLB1 GALNT18

6.07e-041879208f70e5103c6dd96f439f0cceda878963d26850d
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

CA12 GALNT18

6.13e-04188922ee64bc73a2251fd9f374be759b442cf4ed0d19e
ToppCelldroplet-Limb_Muscle-nan-3m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

POGZ GALNT18

6.20e-041899216a4c92dd7a0d60f3691bd3130a091a9a54730f1
ToppCellCOPD-Epithelial-Mesothelial|COPD / Disease state, Lineage and Cell class

CA12 GALNT18

6.20e-041899279bb2593ad5d17f94b17972884241f03a0f43770
ToppCellE17.5-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

PLB1 GALNT18

6.26e-041909215f314517ed47b12d287a12a7d18cb383310e25a
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CA12 GALNT18

6.26e-04190923dcadabbefe0128a5f30ab51234f049ab4d870c6
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CA12 GALNT18

6.33e-0419192963f4f2e852bbb4faf070aafb0d368297abacd3b
ToppCellE15.5-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

PLB1 GALNT18

6.33e-0419192402c341b00f98e8215458766b3c219fff8dcb447
ToppCellP07-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

PLB1 GALNT18

6.33e-04191920f360766490bef3495c42f6421b22a988cfc68fb
ToppCellP03-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

PLB1 GALNT18

6.39e-0419292be5e246b2350398b985767b2fbede17a8dd8cc44
ToppCellPND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PLB1 GALNT18

6.39e-0419292790282d4232311df3dac4ad97c80fc53443beccc
ToppCellPND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PLB1 GALNT18

6.39e-0419292b2d9bffccd6264b4f12d88a0780646ee0b41969f
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CA12 GALNT18

6.39e-0419292562df5e87038c500dd3a003fe5374cb31946b145
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SLC34A2 GALNT18

6.46e-041939280e058c224749b5fe0ba3e944b48317c2371cb63
ToppCellParenchymal-10x5prime-Epithelial-Epi_alveolar-Dividing_AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

CA12 SLC34A2

6.46e-041939244839a606ae2f8e37421bda46d588189e1c943d2
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SLC34A2 GALNT18

6.46e-0419392b991fbbb4618401624f0b3045f0e81a606d3a763
ToppCellE18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PLB1 SLC34A2

6.46e-041939254506c0da2f219f472b95e8935a78b657a8dec41
ToppCellE18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PLB1 SLC34A2

6.46e-04193922d42721fac1bee294ede47d609bebb3e7d36bf0c
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CA12 GALNT18

6.53e-041949293c68c31e39fa44c1d05d7d4997f4f086da4e738
ToppCellfacs-Mammary_Gland-Mammary_Gland-3m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PLB1 SLC8B1

6.53e-0419492550e61a40be2baa59520aaf5912bb99ad094ba15
ToppCellIPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class

SLC34A2 GALNT18

6.59e-0419592fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

CA12 GALNT18

6.59e-04195926477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCellIPF-Multiplet|IPF / Disease state, Lineage and Cell class

SLC34A2 GALNT18

6.59e-0419592eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCellAT2_cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id

CA12 SLC34A2

6.59e-04195920792c1e959e933b10ae987d821ff43020dfdabad
ToppCell(7)_Epithelial-A_(AT2)|World / Lung cell shreds - cell class (v4) and cell subclass (v4)

CA12 SLC34A2

6.59e-0419592c9a6c65ee18d83bf34a4713d306a6e30db1325c2
ToppCellfacs-Mammary_Gland-Mammary_Gland-3m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PLB1 SLC8B1

6.59e-0419592c87edbb8c92a0541b6de2632ac2f9cef44c7e304
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CA12 GALNT18

6.66e-0419692eea66711a16134f86e6c533a5a837ff2e0d7ca7f
ToppCellkidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CA12 SLC34A2

6.66e-0419692e02301642243df483fd066d978317c113c04692b
ToppCellE16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-Sox9_Epi|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PLB1 SLC34A2

6.66e-0419692b236be2fc0144c77a8840081bbb6ac6913e996f8
ToppCellE16.5-Epithelial-Epithelial_Alveolar|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PLB1 SLC34A2

6.66e-04196921756254a61ea92601ed5e223ef4471f010c12216
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

CA12 GALNT18

6.66e-04196926ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0
ToppCellE16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PLB1 SLC34A2

6.66e-0419692caa3c9555e1c656e88246ed31388a818f77610a1
ToppCellkidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CA12 SLC34A2

6.66e-04196921bfc3c85ce9501f52a912e53cbded7de74572b9d
ToppCellLPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

PLB1 SLC34A2

6.73e-0419792b94645d57efe8d9e032bffb8c89af1f425c6421e
ToppCelltumor_Lung-Epithelial_cells-tS1|Epithelial_cells / Location, Cell class and cell subclass

CA12 SLC34A2

6.73e-04197927190143468939cf26c069d125a5e88e4bf026299
ToppCelltumor_Lung-Epithelial_cells-tS1|tumor_Lung / Location, Cell class and cell subclass

CA12 SLC34A2

6.73e-04197928336e6647604e4bdd1596ea554c22203d13782e9
ToppCelldistal-Epithelial-Alveolar_Epithelial_Type_2-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

CA12 SLC34A2

6.80e-0419892de5748c2b66ecc432974cf095ecd241369579f7c
ToppCellmedial-2-Epithelial-Alveolar_Epithelial_Type_2|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

CA12 SLC34A2

6.80e-0419892102a4cbb138adbfba11ed955420095daa098532f
ToppCellAT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id

CA12 SLC34A2

6.80e-0419892893036558a9ad86b57f9e735df35812e9d18739e
ToppCellmedial-Epithelial-Alveolar_Epithelial_Type_2-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

CA12 SLC34A2

6.80e-04198927caeed2d5dc78866023c8f38edcec9886baa9f2c
ToppCellSmart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CA12 SLC34A2

6.80e-0419892399760b6b6fef8639ded53b14f251b9fce600e81
ToppCellmedial-Epithelial-Alveolar_Epithelial_Type_2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

CA12 SLC34A2

6.80e-041989253e5d76831d70b9a476f3ef3a81e13eda974d543
ToppCell(06)_OLFM4+|World / shred by cell type by condition

CA12 SLC34A2

6.87e-0419992c773b9180dbfec9c19d4098dd43332e6f6050372
ToppCellTracheal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

GET1 GALNT18

6.87e-0419992079931e7196719f22a89cfad82f452ec67219ee5
ToppCell(7)_Epithelial_cells-(7)_Epithelial-A_(AT2)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)

CA12 SLC34A2

6.87e-041999209cf004032e5af912ee0cdde6e24ce3bcf7673cd
ToppCellTransplant_Alveoli_and_parenchyma-Mesenchymal-Mesothelium|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X

CA12 GALNT18

6.87e-04199926cfefd81e8a1a883fb4279ac4ab0b298ed2a0817
ToppCelldistal-2-Epithelial-Alveolar_Epithelial_Type_2|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

CA12 SLC34A2

6.87e-041999221b44031bc5182ee23ba5e206042b2e5e4ee0c3c
ToppCellTracheal-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

SLC34A2 GALNT18

6.93e-0420092fe493b0454a20498e9ada482bf55de64519f6c35
DrugAntipyrine [60-80-0]; Up 200; 21.2uM; HL60; HG-U133A

LRIG2 POGZ SLC8B1

5.31e-05199931989_UP
Drugcholine

PLB1 CA12 SLC8B1

2.17e-0432093CID000000305
Drugglycerophosphoinositol

PLB1 SLC34A2

2.59e-046292CID000167572
Drugp-nitrophenyl acetate

PLB1 CA12

4.65e-048392CID000013243
Drugthiazide

CA12 SLC34A2

7.29e-0410492CID000002720
Drugdansylamide

CA12 GET1

1.08e-0312792CID000065077
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

CA12 POGZ

1.93e-03170925260_DN
DrugEmetine dihydrochloride [316-42-7]; Down 200; 7.2uM; MCF7; HT_HG-U133A

CA12 GET1

1.97e-03172922801_DN
DrugEmetine dihydrochloride [316-42-7]; Down 200; 7.2uM; MCF7; HT_HG-U133A

CA12 GET1

2.09e-03177924827_DN
Drugthapsigargin; Down 200; 0.1uM; PC3; HT_HG-U133A

CA12 GET1

2.13e-03179927103_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A

UNC50 POGZ

2.20e-03182921951_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

UNC50 POGZ

2.23e-03183927136_DN
DrugBetamethasone [378-44-9]; Up 200; 10.2uM; HL60; HG-U133A

CA12 POGZ

2.23e-03183921590_UP
DrugMitoxantrone dihydrochloride [70476-82-3]; Down 200; 7.8uM; PC3; HT_HG-U133A

LRIG2 POGZ

2.25e-03184926755_DN
DrugCorticosterone [50-22-6]; Down 200; 11.6uM; MCF7; HT_HG-U133A

CA12 POGZ

2.33e-03187923244_DN
DrugBetulinic acid [472-15-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A

CA12 SLC8B1

2.35e-03188923281_UP
DrugICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A

CA12 SLC8B1

2.37e-03189926997_DN
DrugAstemizole [68844-77-9]; Down 200; 8.8uM; PC3; HT_HG-U133A

CA12 GET1

2.42e-03191924471_DN
DrugFludrocortisone acetate [514-36-3]; Up 200; 9.4uM; HL60; HT_HG-U133A

CA12 SLC8B1

2.42e-03191922368_UP
DrugFenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A

CA12 SLC8B1

2.45e-03192923612_DN
DrugBeta-sistosterol [83-46-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A

CA12 SLC8B1

2.47e-03193924154_DN
Drugikarugamycin; Down 200; 2uM; MCF7; HT_HG-U133A_EA

POGZ SLC8B1

2.47e-0319392866_DN
DrugPHA-00745360 [351320-33-7]; Down 200; 10uM; PC3; HT_HG-U133A

CA12 POGZ

2.50e-03194924559_DN
DrugEpivincamine [6835-99-0]; Up 200; 11.2uM; HL60; HG-U133A

CA12 SLC8B1

2.50e-03194921783_UP
DrugBAS 012416453; Down 200; 38uM; PC3; HT_HG-U133A

POGZ SLC8B1

2.50e-03194926876_DN
Drug2-deoxy-D-glucose; Down 200; 10000uM; MCF7; HG-U133A

CA12 SLC8B1

2.50e-0319492344_DN
Drugdiclofenac sodium; Down 200; 10uM; MCF7; HG-U133A

CA12 SLC34A2

2.53e-0319592333_DN
DrugCanrenoic acid potassium salt [2181-04-6]; Up 200; 10uM; PC3; HT_HG-U133A

CA12 POGZ

2.53e-03195927135_UP
Drugprochlorperazine dimaleate salt; Down 200; 10uM; MCF7; HT_HG-U133A_EA

LRIG2 POGZ

2.53e-03195921053_DN
Druggenistein; Down 200; 1uM; MCF7; HG-U133A

POGZ SLC34A2

2.53e-0319592268_DN
Drug5286656; Up 200; 50uM; MCF7; HT_HG-U133A_EA

LRIG2 SLC8B1

2.53e-0319592889_UP
DrugDipyridamole [58-32-2]; Down 200; 8uM; HL60; HG-U133A

POGZ SLC8B1

2.53e-03195922017_DN
DrugOxprenolol hydrochloride [6452-73-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A

CA12 POGZ

2.55e-03196923568_DN
DrugHyoscyamine (L) [101-31-5]; Down 200; 13.8uM; PC3; HT_HG-U133A

LRIG2 SLC8B1

2.55e-03196922108_DN
Drugretinoic acid; Down 200; 1uM; HL60; HG-U133A

CA12 SLC34A2

2.55e-0319692390_DN
DrugNalbuphine hydrochloride [23277-43-2]; Down 200; 10.2uM; HL60; HG-U133A

LRIG2 POGZ

2.55e-03196921379_DN
DrugIvermectin [70288-86-7]; Down 200; 4.6uM; PC3; HT_HG-U133A

CA12 POGZ

2.55e-03196922051_DN
DrugLY294002; Down 200; 10uM; MCF7; HT_HG-U133A

CA12 SLC8B1

2.55e-03196925937_DN
DrugIproniazide phosphate [305-33-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A

CA12 SLC34A2

2.55e-03196922288_DN
DrugNU1025; Down 200; 100uM; MCF7; HG-U133A

SLC34A2 SLC8B1

2.55e-0319692313_DN
DrugBetazole hydrochloride; Down 200; 27uM; HL60; HT_HG-U133A

POGZ SLC8B1

2.55e-03196921854_DN
DrugFluvoxamine maleate [61718-82-9]; Up 200; 9.2uM; MCF7; HT_HG-U133A

SLC34A2 SLC8B1

2.55e-03196924114_UP
DrugPargyline hydrochloride [306-07-0]; Up 200; 20.4uM; HL60; HG-U133A

CA12 SLC8B1

2.55e-03196921418_UP
DrugSC-58125; Down 200; 10uM; SKMEL5; HG-U133A

CA12 POGZ

2.55e-0319692507_DN
Drugprostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A

CA12 SLC8B1

2.55e-03196926590_DN
DrugGSK-3 Inhibitor IX; Down 200; 0.5uM; PC3; HT_HG-U133A

CA12 POGZ

2.55e-03196926585_DN
DrugIsoxsuprine hydrochloride [579-56-6]; Up 200; 11.8uM; PC3; HG-U133A

CA12 LRIG2

2.55e-03196921904_UP
DrugMinaprine dihydrochloride [25953-17-7]; Up 200; 10.8uM; HL60; HG-U133A

LRIG2 SLC8B1

2.55e-03196921968_UP
DrugQuinethazone [73-49-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A

POGZ SLC34A2

2.55e-03196923875_UP
DrugTamoxifen citrate [54965-24-1]; Down 200; 7uM; MCF7; HT_HG-U133A

CA12 SLC8B1

2.58e-03197926768_DN
DrugMevalonic-D, L acid lactone [674-26-0]; Up 200; 30.8uM; HL60; HT_HG-U133A

CA12 SLC34A2

2.58e-03197922718_UP
DrugSulfadiazine [68-35-9]; Down 200; 16uM; PC3; HT_HG-U133A

CA12 POGZ

2.58e-03197921810_DN
DrugAlcuronium chloride [15180-03-7]; Down 200; 5.4uM; MCF7; HT_HG-U133A

CA12 SLC8B1

2.58e-03197927345_DN
DrugSulfameter [651-06-9]; Up 200; 14.2uM; PC3; HT_HG-U133A

CA12 POGZ

2.58e-03197925732_UP
DrugProbenecid [57-66-9]; Down 200; 14uM; MCF7; HT_HG-U133A

POGZ SLC8B1

2.58e-03197924771_DN
DrugMinoxidil [38304-91-5]; Up 200; 19.2uM; MCF7; HT_HG-U133A

CA12 SLC34A2

2.58e-03197921496_UP
DrugSB 203580; Up 200; 1uM; MCF7; HT_HG-U133A

POGZ SLC8B1

2.58e-03197927061_UP
DrugHarmalol hydrochloride dihydrate [6028-07-5]; Down 200; 14.6uM; MCF7; HT_HG-U133A

CA12 SLC8B1

2.58e-03197922892_DN
DrugGSK-3 Inhibitor IX; Down 200; 0.5uM; MCF7; HT_HG-U133A

CA12 SLC8B1

2.58e-03197927101_DN
Drug0316684-0000 [391209-55-5]; Up 200; 10uM; MCF7; HT_HG-U133A

CA12 POGZ

2.58e-03197927093_UP
DrugPraziquantel [55268-74-1]; Up 200; 12.8uM; MCF7; HT_HG-U133A

CA12 SLC8B1

2.58e-03197923189_UP
DrugMidecamycin [35457-80-8]; Up 200; 5uM; PC3; HT_HG-U133A

CA12 SLC34A2

2.58e-03197926745_UP
DrugGriseofulvin [126-07-8]; Up 200; 11.2uM; PC3; HT_HG-U133A

CA12 SLC34A2

2.58e-03197923664_UP
DrugLevodopa [59-92-7]; Up 200; 20.2uM; HL60; HG-U133A

LRIG2 SLC8B1

2.58e-03197921972_UP
Drugradicicol; Down 200; 0.1uM; SKMEL5; HG-U133A

POGZ SLC34A2

2.58e-0319792493_DN
DrugAltretamine [654-05-6]; Up 200; 19uM; PC3; HT_HG-U133A

CA12 SLC34A2

2.58e-03197924627_UP
DrugDoxycycline hydrochloride [10592-13-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A

POGZ SLC8B1

2.58e-03197927195_DN
Drugthioridazine hydrochloride; Up 200; 1uM; MCF7; HG-U133A

CA12 POGZ

2.58e-0319792422_UP
DrugIsoniazid [54-85-3]; Up 200; 29.2uM; PC3; HT_HG-U133A

POGZ SLC34A2

2.58e-03197925840_UP
DrugAztreonam [78110-38-0]; Up 200; 9.2uM; HL60; HG-U133A

CA12 LRIG2

2.60e-03198921435_UP
DrugNeostigmine bromide [114-80-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A

CA12 POGZ

2.60e-03198923294_DN
DrugAvermectin B1 [71751-41-2]; Down 200; 4.8uM; PC3; HT_HG-U133A

CA12 POGZ

2.60e-03198925864_DN
DrugSulfaguanidine [57-67-0]; Down 200; 18.6uM; PC3; HG-U133A

POGZ SLC8B1

2.60e-03198921913_DN
DrugFursultiamine Hydrochloride [2105-43-3]; Up 200; 9.2uM; HL60; HT_HG-U133A

CA12 SLC34A2

2.60e-03198922929_UP
DrugAlprenolol hydrochloride [13707-88-5]; Down 200; 14uM; HL60; HG-U133A

CA12 POGZ

2.60e-03198921571_DN
Drugrofecoxib; Up 200; 10uM; HL60; HG-U133A

CA12 SLC34A2

2.60e-0319892371_UP
DrugOxytetracycline dihydrate [6153-64-6]; Up 200; 8uM; MCF7; HT_HG-U133A

SLC34A2 SLC8B1

2.60e-03198923170_UP
Drugrottlerin; Down 200; 10uM; MCF7; HT_HG-U133A_EA

LRIG2 SLC8B1

2.60e-0319892914_DN
DrugMeclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A

SLC34A2 SLC8B1

2.60e-03198924729_DN
DrugOxamniquine [21738-42-1]; Down 200; 14.4uM; MCF7; HT_HG-U133A

CA12 SLC8B1

2.60e-03198927344_DN
DrugEtodolac [41340-25-4]; Up 200; 14uM; MCF7; HT_HG-U133A

POGZ SLC8B1

2.60e-03198927006_UP
DrugPiperidolate hydrochloride [129-77-1]; Down 200; 11.2uM; MCF7; HT_HG-U133A

CA12 POGZ

2.60e-03198923551_DN
DrugSpectinomycin dihydrochloride [21736-83-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A

CA12 POGZ

2.60e-03198924773_DN
Drugrotenone; Down 200; 1uM; MCF7; HT_HG-U133A

CA12 SLC34A2

2.60e-03198925915_DN
DrugFlucytosine [2022-85-7]; Up 200; 31uM; MCF7; HT_HG-U133A

LRIG2 SLC8B1

2.60e-03198925289_UP
Diseaseurate measurement, bone density

PLB1 GALNT18

1.13e-0261982EFO_0003923, EFO_0004531

Protein segments in the cluster

PeptideGeneStartEntry
AGILGICIVVVVSIW

CA12

311

O43570
PTRVAGGVGITCWIL

GET1

146

O00258
LGIRVWQCGGSVEVL

GALNT18

361

Q6P9A2
GLVPVWVVVVIAGTA

SLC8B1

386

Q6J4K2
VLVWLGEVLGVIGDC

POGZ

1301

Q7Z3K3
VGLVVGIIGTVVWRC

PLB1

1426

Q6P1J6
GWRVLVGVGVPVVFI

SLC34A2

551

O95436
WVVLIDCVGVGLLIA

UNC50

116

Q53HI1
DGWTTVGIVIIVVVC

LRIG2

801

O94898